Elos Medtech AB has entered into an agreement to acquire IK Partners' stake in KLINGEL Holding GmbH. KLINGEL is a full-service provider of highly complex high-end components and customized products in the field of medical technology. This sale is part of the IK VIII Fund of IK Partners.
Founded in 1986 and headquartered in Pforzheim, Germany, KLINGEL has evolved into a Contract Development and Manufacturing Organization (CDMO) specializing in medical technology. The company serves customers in orthopedics, spine, trauma, surgical robotics, endoscopy, and dentistry. KLINGEL offers a wide range of services along the entire value chain, from development to production and sterile packaging. With eight production sites in southern Germany and Switzerland, KLINGEL has transitioned from a regional contract manufacturer in the DACH market to an international MedTech CDMO, now serving MedTech OEMs worldwide. KLINGEL's growth has been driven by the introduction of new production methods and strategic acquisitions, including GEHRING CUT, Bächler Feintech, puracon, and Ruetschi. The KLINGEL Medical Group employs around 900 people at its headquarters in Pforzheim and partner companies, including Josef Ganter Feinmechanik in Dauchingen, puracon in Rosenheim, Bächler Feintech in Hölstein and Matzingen, and Ruetschi in Renquishausen (southern Germany), Muntelier, and Yverdon-les-Bains (both in Switzerland).
Elos Medtech is a development and manufacturing partner for medical devices and components, with a special focus on dental and orthopedic implants and instruments. With offices in Sweden, Denmark, China, and the USA, the company serves international customers in the medical technology sector. Elos Medtech employs over 650 people and generates sales of approximately SEK 950 million. The company has been listed on NASDAQ Stockholm AB since 1989, with its B-share categorized under the healthcare segment of the Mid Cap Index.
IK Partners, a European private equity firm, focuses on investments in the Benelux, DACH region, France, the Nordics, and the UK. Led by CEO Christopher Masek, IK Partners was originally founded as Industri Kapital by Björn Savén and Kim Wahl. The firm has its roots in Enskilda Ventures, which supported Björn Savén in founding the Scandinavian Acquisition Capital Fund (SAC) in 1989 and established the London office. In 1993, Industri Kapital separated from Skandinaviska Enskilda Banken through a management buyout and renamed the 1989 fund. That year, the company also opened offices in Stockholm and Oslo.